Gikakis Nicolas's Insider Trades & SAST Disclosures
Gikakis Nicolas's most recent trade in Aethlon Medical Inc was a trade of 142,857 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on April 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gikakis Nicolas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aethlon Medical Inc | Nicolas Gikakis | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 23 Apr 2025 | 142,857 | 174,320 (1%) | 1% | 0.4 | 50,000 | Common Stock |
| Aethlon Medical Inc | Nicolas Gikakis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 31 Mar 2025 | 3,289 | 31,463 (0%) | 0% | 0.4 | 1,177 | Common Stock |
| Aethlon Medical Inc | Nicolas Gikakis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.86 per share. | 31 Dec 2024 | 3,289 | 34,752 (0%) | 0% | 0.9 | 2,829 | Common Stock |
| Aethlon Medical Inc | Nicolas Gikakis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.47 per share. | 30 Sep 2024 | 3,289 | 38,041 (0%) | 0% | 0.5 | 1,533 | Common Stock |
| Aethlon Medical Inc | Nicolas Gikakis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 28 Jun 2024 | 5,244 | 41,330 (0%) | 0% | 0.5 | 2,617 | Common Stock |
| Aethlon Medical Inc | Nicolas Gikakis | Director | Grant, award, or other acquisition of securities at price $ 1.52 per share. | 16 Apr 2024 | 32,894 | 46,574 (0%) | 0% | 1.5 | 49,999 | Common Stock |
| Aethlon Medical Inc | Nicolas Gikakis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. | 29 Mar 2024 | 1,954 | 13,680 (0%) | 0% | 1.7 | 3,283 | Common Stock |
| Aethlon Medical Inc | Gikakis Nicolas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.19 per share. | 29 Dec 2023 | 1,954 | 15,634 (0%) | 0% | 2.2 | 4,279 | Common Stock |
| Aethlon Medical Inc | Gikakis Nicolas | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.23 per share. | 29 Sep 2023 | 19,541 | 175,873 (1%) | 0% | 0.2 | 4,494 | Common Stock |
| Aethlon Medical Inc | Nicolas Gikakis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 195,414 | 195,414 (2%) | 2% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges